Cancer Commons founder Marty Tenenbaum, Ph.D., spoke on May 31 at Washington University in St. Louis during an invitation-only conference focused on new approaches to biomedical innovation. Marty, who founded Cancer Commons after his own battle with melanoma, participated in the “Opportunities and Challenges in Oncology Therapeutic Development” session, which explored promising new innovations that have not yet received the attention they merit. During the… Read more »
Cancer Commons founder Marty Tenenbaum, Ph.D., will speak May 11 at the Stanford AI Salon, a regular event hosted by the Stanford University Artificial Intelligence Laboratory. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments in a talk titled “How can AI cure cancer?” According to the event website, “AI… Read more »
Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Bio-IT World Conference & Expo in Boston, which runs May 15 to 18. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments. Read the synopsis of Marty’s presentation, entitled “Can AI Beat Cancer?“: AI can beat go and drive cars, but can… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will speak next week at the Bridging Clinical Research & Clinical Health Care Collaborative in National Harbor, Maryland. His presentation will be featured in a session focused on precision oncology, which runs from 3:30 to 5:00 pm on Wednesday April 4. The Bridging Clinical Research & Clinical Health Care Collaborative is “the only forum where clinical research and health care… Read more »
A presentation by Cancer Commons founder Marty Tenenbaum, PhD, was well-received last month at the Precision Medicine World Conference (PMWC) in Silicon Valley. His talk, “How AI will Cure Cancer,” discussed the role of artificial intelligence in finding better cancer treatments. In a separate event at the same conference, Cancer Commons medical director Kevin Knopf, MD, spoke about the future of personalized medicine as part of a panel… Read more »
Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Precision Medicine World Conference (PMWC) in Silicon Valley, which runs Jan 22–24. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments. Read the synopsis of Marty’s presentation, entitled “How AI will Cure Cancer”: From an AI perspective, finding effective treatments for cancer… Read more »
In a new guest blog post for CollabRx, Cancer Commons scientist and project manager Lisandra West-Odell discusses how we’re harnessing the power of data analytics to improve treatment for cancer patients, starting with brain cancer: “I am reminded of the old adage: ‘Lessons come from the journey, not the destination.’ Where one patient’s story can only exist as an anecdote, many stories can be… Read more »
Hear from some more cancer fighters: Avid @ArizonaCoyotes fan Tom (Labonte) from Chandler and @judefox10 #YotesFightCancer pic.twitter.com/LVlQ0Z7NW0 — FOX Sports Arizona (@FOXSPORTSAZ) November 5, 2017 Fox 10 News sports anchor Jude LaCava is a long-time proponent of Cancer Commons who has sent many patients and caregivers our way to receive extra guidance for their cancer treatment, including Super Patient Mary Beth Smith. This past weekend,… Read more »
We at Cancer Commons express our deep gratitude to the H8 Cancer Foundation, which has generously made our organization a major beneficiary of its gifts since 2015. Founded by oncologist Dr. Simeon Jaggernauth, H8 Cancer is “dedicated to raising funds for research and to promote awareness of better treatment options to save lives.” Recently, we had the honor of attending Tomstock, an annual summer music festival to benefit H8… Read more »
Cancer Commons founder Marty Tenenbaum wrote a letter to the editor that has now been published in The Economist. His piece discusses the importance of using data to accelerate improvement of cancer treatment. From the letter: “The oncology drug pipeline is full of promising immunotherapies and targeted treatments (Technology Quarterly on cancer, September 16th). Unfortunately, no one knows the optimal way to use them. Doctors and patients… Read more »
